U
Zealand Pharma A/S ZLDPF
$75.88 -$7.17-8.63% OTC PK
Recommendation
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income -63.32M 1.15B -47.30M -41.59M -39.26M
Total Depreciation and Amortization 1.13M 944.80K 840.60K 506.80K 912.30K
Total Amortization of Deferred Charges -- -- -- 2.36M --
Total Other Non-Cash Items 18.46M 157.12M 1.11M -6.23M -2.79M
Change in Net Operating Assets -25.78M -14.23M -25.29M 19.17M -2.39M
Cash from Operations -69.52M 1.30B -70.64M -25.79M -43.52M
Capital Expenditure -570.80K -977.00K -910.40K -168.10K -37.10K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -3.59M 3.33M -- --
Other Investing Activities -133.43M -234.89M 75.81M 21.71M -895.13M
Cash from Investing -134.00M -239.46M 78.24M 21.54M -895.16M
Total Debt Issued -- -- -- 0.00 0.00
Total Debt Repaid -5.42M -4.43M -4.34M -4.59M -4.18M
Issuance of Common Stock 1.90M 27.09M 3.55M 81.00K 5.11M
Repurchase of Common Stock -74.76M -332.41M -- 0.00 -270.80M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -100.00K -2.36M
Cash from Financing -12.26M -47.12M -111.60K -658.10K -40.12M
Foreign Exchange rate Adjustments 16.63M -25.47M -411.60K 517.50K -288.40K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -199.15M 983.85M 7.07M -4.39M -979.09M